Boston Cambridge Biotech Networks

  • Home
  • About
  • News
    • All News
    • BCBN Trending News
  • Jobs
    • All Jobs
    • Post a Job
  • BN Connect
    • BN Connect
    • About Biotech Networks Connect
  • Advertise
  • Subscribe
  • Contact
News Ticker
  • [ October 26, 2026 ] Kos Biotechnology Partners Announces Strategic Investment in Golden Age Health to Accelerate Global Access to Rare Disease Therapies News
  • [ October 26, 2026 ] Tango Therapeutics cuts 14% of workforce to focus on clinical cancer programs News
  • [ October 26, 2026 ] STAT+: Five biotech updates to read after ESMO this weekend News
  • [ October 26, 2026 ] Vyome Co-Founder Dr. Shiladitya Sengupta Promoted to Professor at Harvard Medical School News
  • [ October 26, 2026 ] Sumitomo Pharma America Announces Enzomenib (DSP-5336) Receives FDA Breakthrough Therapy Designation for Treatment of R/R KMT2A-Rearranged Acute Leukemia News
HomeNewsTango Therapeutics cuts 14% of workforce to focus on clinical cancer programs

Tango Therapeutics cuts 14% of workforce to focus on clinical cancer programs

October 26, 2026 BCBN News, Syndication Comments Off on Tango Therapeutics cuts 14% of workforce to focus on clinical cancer programs

This is the second workforce reduction in recent years for the cancer-focused biotech, which cut about 20% of staff in April 2025.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks

Previous

STAT+: Five biotech updates to read after ESMO this weekend

Next

Kos Biotechnology Partners Announces Strategic Investment in Golden Age Health to Accelerate Global Access to Rare Disease Therapies

POST A JOB

BCBN Featured Jobs

Posts by BCBNJobs

Copyright © 2026 Biotech Networks, LLC

Save Time—Get Weekly/Trending/Daily News & Jobs Delivered to Your Inbox